title: Induction of cholinergic and adrenergic differentiation in N-18 cells by differentiation agents and DNA demethylating agents.
abstract: Effects of various differentiating agents and DNA demethylating agents on the expression of choline acetyltransferase (ChAT) and tyrosine hydroxylase (TH), marker enzymes for cholinergic and adrenergic differentiation, respectively, were examined in N-18 neuroblastoma cells. Retinoic acid (RA) and a medium conditioned over C6-glioma cells (GCM), which have been shown to enhance the ChAT activity of PC12 cells, NG108-15 cells and fetal rat brain cells, did not induce ChAT activity of N-18 cells. Treatment of the cells with the DNA demethylating agents alone also did not affect ChAT activity. But after pretreatment of the cells with the DNA demethylating agents, ChAT activity of N-18 cells was greatly increased by either RA or GCM. TH activity of N-18 cells was enhanced by forskolin, an activator of adenylate cyclase. The pretreatment of the cells with the DNA demethylating agents greatly enhanced the induction of TH activity by forskolin. Levels of ChAT and TH messenger RNA were altered in accordance with changes in ChAT and TH activities. Possible mechanisms of the actions of the demethylating agents on cholinergic and adrenergic differentiation are discussed.
authors.affiliation: Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Okuse
authors.forename: N
authors.initials: N
authors.lastname: Mizuno
authors.forename: I
authors.initials: I
authors.lastname: Matsuoka
authors.forename: K
authors.initials: K
authors.lastname: Kurihara
mesh_terms: D000109:Acetylcholine / Q000502:physiology*; D000970:Antineoplastic Agents / Q000494:pharmacology; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D002795:Choline O-Acetyltransferase / Q000187:drug effects / Q000235:genetics; D017077:Culture Media, Conditioned; D004273:DNA, Neoplasm / Q000187:drug effects*; D000077209:Decitabine; D008745:Methylation; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D012333:RNA, Messenger / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000166:cytology / Q000187:drug effects*; D014407:Tumor Cells, Cultured; D014446:Tyrosine 3-Monooxygenase / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D017077:Culture Media, Conditioned; D004273:DNA, Neoplasm; D012333:RNA, Messenger; D000077209:Decitabine; D014446:Tyrosine 3-Monooxygenase; D002795:Choline O-Acetyltransferase; D001374:Azacitidine; D000109:Acetylcholine